| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.2M | -65.0% |
| Cost of Revenue | $5.5M | -52.6% |
| Gross Profit | $28.7M | -66.7% |
| R&D Expense | $17.4M | +16.5% |
| SG&A Expense | $14.3M | +23.5% |
| Operating Income | -$27.0M | -158.6% |
| Pre-tax Income | -$18.8M | -141.3% |
| Income Tax | -$4.6M | -151.3% |
| Net Income | -$14.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.0M | -74.1% |
| Short-term Investments | $58.3M | +4543.6% |
| Accounts Receivable | $3.5M | -83.4% |
| Inventory | $5.3M | +165.0% |
| Current Assets | $92.7M | -19.4% |
| Total Assets | $123.1M | -23.1% |
| Current Liabilities | $3.9M | -69.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.6M | -84.0% |
| Capital Expenditures | $1.4M | +113.2% |
| Investing Cash Flow | -$58.2M | -1519.2% |
| Financing Cash Flow | -$14.0M | -3215.9% |
| Free Cash Flow | $5.1M | -87.3% |
| -138.8% |
| EPS (Basic) | -$0.45 | -135.4% |
| EPS (Diluted) | -$0.45 | -136.6% |
| Total Liabilities |
| $8.6M |
| -66.5% |
| Stockholders' Equity | $114.5M | -14.8% |